Previous studies have pointed out that sevoflurane (Sef) preconditioning could relieve myocardial ischemia/reperfusion (I/R) injury, but the mechanisms is still unknown.
Methods:
C57BL/6 mice model of myocardial I/R injury was established to evaluate the function of Sef. Briefly, Sef was inhaled before I/R operation. The levels of TIMP3, oxidative damage-related factors, and mitogen activated protein kinases (MAPKs) pathway-related factors were measured by qRT-PCR and western blot. Myocardial infarction (MI) area was detected by triphenyl tetrazolium chloride (TTC) staining assay.
Results:
Sef preconditioning reduced MI area in myocardial I/R injury mice and upregulated TIMP3 expression in myocardial tissues of I/R mice. In addition, downregulation of TIMP3 reversed the alleviating effects of Sef pretreatment on myocardial oxidative damage and inhibited the effect of Sef pretreatment on MAPKs pathway activity.
Conclusion:
Sef preconditioning ameliorated myocardial I/R injury by modulating MAPKs pathway activity via upregulating TIMP3.
FrankABonneyMBonneyS, et al. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth2012; 16: 123–132.
2.
JenningsRBSommersHMSmythGA, et al. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol1960; 70: 68–78.
3.
AdameovaADBhullarSKElimbanV, et al. Activation of β1-adrenoceptors may not be involved in arrhythmogenesis in ischemic heart disease. Rev Cardiovasc Med2018; 19: 97–101.
4.
MunteanDMOrdodiVFerreraR, et al. Volatile anaesthetics and cardioprotection: lessons from animal studies. Fundam Clin Pharmacol2013; 27: 21–34.
5.
HosseinifardHGhadimiNKavehS, et al. Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis. J Cardiovasc Thorac Res2020; 12: 1–9.
6.
OrriachJLAliagaMROrtegaMG, et al. Sevoflurane in intraoperative and postoperative cardiac surgery patients. Our experience in intensive care unit with sevoflurane sedation. Curr Pharm Des2013; 19: 3996–4002.
7.
PasqualinRCMostardaCTSouzaLE, et al. Sevoflurane preconditioning during myocardial ischemia-reperfusion reduces infarct size and preserves autonomic control of circulation in rats. Acta Cir Bras2016; 31: 338–345.
8.
ZhuJJiangXShiE, et al. Sevoflurane preconditioning reverses impairment of hippocampal long-term potentiation induced by myocardial ischaemia-reperfusion injury. Eur J Anaesthesiol2009; 26: 961–968.
9.
BrewKNagaseH.The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta2010; 1803: 55–71.
10.
StohrRKappelBACarnevaleD, et al. TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice. Mol Metab2015; 4: 741–752.
11.
ZhabyeyevPDasSKBasuR, et al. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease. Am J Physiol Heart Circ Physiol2018; 314: H978–H990.
12.
TakawaleAZhangPAzadA, et al. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis. Am J Physiol Heart Circ Physiol2017; 313: H224–H236.
13.
LiuHJingXDongA, et al. Overexpression of TIMP3 protects against cardiac ischemia/reperfusion injury by inhibiting myocardial apoptosis through ROS/Mapks pathway. Cell Physiol Biochem2017; 44: 1011–1023.
WeberNCSchlackW.Inhalational anaesthetics and cardioprotection. Handb Exp Pharmacol2008; 182: 187–207.
16.
LandoniGFochiOTritapepeL, et al. Cardiac protection by volatile anesthetics. A review. Minerva Anestesiol2009; 75: 269–273.
17.
ChoYJNamKKimTK, et al. Sevoflurane, propofol and carvedilol block myocardial protection by limb remote ischemic preconditioning. Int J Mol Sci2019; 20: E269.
18.
VaradarajanSGAnJNovalijaE, et al. Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(2+) loading in intact hearts. Anesthesiology2002; 96: 125–133.
19.
QiaoSGSunYSunB, et al. Sevoflurane postconditioning protects against myocardial ischemia/reperfusion injury by restoring autophagic flux via an NO-dependent mechanism. Acta pharmacol Sin2019; 40: 35–45.
20.
WuJYuJXieP, et al. Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2-STAT3 pathway. PeerJ2017; 5: e3196.
21.
ZhangJWangCYuS, et al. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep2014; 4: 7317.
22.
ZhaoJWangFZhangY, et al. Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition. Circulation2013; 128: S121–S129.
23.
XieDZhaoJGuoR, et al. Sevoflurane pre-conditioning ameliorates diabetic myocardial ischemia/reperfusion injury via differential regulation of p38 and ERK. Sci Rep2020; 10: 23.
24.
WangLLiH.MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3. Biosci Rep2020; 40: BSR20193653. DOI: 10.1042/BSR20193653.
25.
HeMPangJSunH, et al. P14ARF inhibits regional inflammation and vascularization in intervertebral disc degeneration by upregulating TIMP3. Am J Physiol Cell Physiol2020; 318: C751–C761.
26.
HuangHLLiuYMSungTY, et al. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis. Theranostics2019; 9: 6676–6689.
27.
FanDTakawaleABasuR, et al. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Cardiovascular Res2014; 103: 268–280.
28.
KandalamVBasuRAbrahamT, et al. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction. Am J Physiol Heart Circ Physiol2010; 299: H1012–H1023.
29.
ChintalgattuVGreenbergJSinghS, et al. Utility of glycosylated TIMP3 molecules: inhibition of MMPs and TACE to improve cardiac function in rat myocardial infarct model. Pharmacol Res Perspect2018; 6: e00442.
30.
YaoJJiangSLLiuW, et al. Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction. Rejuvenation Res2012; 15: 495–506.
31.
KimEKChoiEJ.Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta2010; 1802: 396–405.
32.
FengMWangLChangS, et al. Penehyclidine hydrochloride regulates mitochondrial dynamics and apoptosis through p38MAPK and JNK signal pathways and provides cardioprotection in rats with myocardial ischemia-reperfusion injury. Eur J Pharm Sci2018; 121: 243–250.
33.
RaniNBhartiSManchandaM, et al. Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by naringin dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion. PloS One2013; 8: e82577. DOI: 10.1371/journal.pone.0082577.
34.
EngelbrechtAMEngelbrechtPGenadeS, et al. Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway. J Mol Cell Cardiol2005; 39: 940–954.
35.
LinBXuJFengDG, et al. DUSP14 knockout accelerates cardiac ischemia reperfusion (IR) injury through activating NF-kappaB and MAPKs signaling pathways modulated by ROS generation. Biochem Biophys Res Commun2018; 501: 24–32.
